UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
IPHA holding history
Innate Pharma SA in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IPHA overviewAll 13F holders of IPHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,363
- Value
- $2.51K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,363 | $2.51K | <0.1% | +502+58.3% | Added | Holders |
| Q1 2026 | 861 | $1.10K | <0.1% | −86−9.1% | Reduced | Holders |
| Q4 2025 | 947 | $1.66K | <0.1% | −3,850−80.3% | Reduced | Holders |
| Q3 2025 | 4,797 | $9.26K | <0.1% | −1,160−19.5% | Reduced | Holders |
| Q2 2025 | 5,957 | $10.8K | <0.1% | −3,044−33.8% | Reduced | Holders |
| Q1 2025 | 9,001 | $16.0K | <0.1% | +5,491+156.4% | Added | Holders |
| Q4 2024 | 3,510 | $6.46K | <0.1% | −4,898−58.3% | Reduced | Holders |
| Q3 2024 | 8,408 | $19.3K | <0.1% | +8,111+2,731.0% | Added | Holders |
| Q2 2024 | 297 | $576 | <0.1% | +87+41.4% | Added | Holders |
| Q1 2024 | 210 | $604 | <0.1% | +64+43.8% | Added | Holders |
| Q4 2023 | 146 | $409 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 146 | $369 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 146 | $449 | <0.1% | −1,113−88.4% | Reduced | Holders |
| Q1 2023 | 1,259 | $3.59K | <0.1% | +1,113+762.3% | Added | Holders |
| Q4 2022 | 146 | $545 | <0.1% | −4,359−96.8% | Reduced | Holders |
| Q3 2022 | 4,505 | $9.00K | <0.1% | +1,549+52.4% | Added | Holders |
| Q2 2022 | 2,956 | $8.00K | <0.1% | +2,956 | New | Holders |